Kyung Eun Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kyung Eun Park has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Ha-Kyeong Won
Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju 28644, Korea
6 shared publications - Woo-Jung Song
Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
6 shared publications - Jiwon Lee
Institute of Allergy and Clinical Immunology, Asan Medical Research Center, Seoul, Korea
3 shared publications - Jun-Pyo Choi
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
3 shared publications - Noeul Kang
Division of Allergy, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul South Korea
3 shared publications - Sang-Heon Cho
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
3 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
Interpretive framework for Cough Hypersensitivity Questionnaire scores in chronic cough
Extract Chronic cough (>8 weeks) is a prevalent condition that substantially impairs quality of life (QoL) [1, 2]. While some cases are attributable to identifiable etiologies, chronic cough that remains unexplained or persists despite treatment of associated conditions represents an important unmet medical need [3]. Cough hypersensitivity has recently emerged as a key pathophysiological feature and treatable trait in these patients [4–7].
- 23 July 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
Open AccessInterpretive framework for Cough Hypersensitivity Questionnaire scores in chronic cough
Extract Chronic cough (>8 weeks) is a prevalent condition that substantially impairs quality of life (QoL) [1, 2]. While some cases are attributable to identifiable etiologies, chronic cough that remains unexplained or persists despite treatment of associated conditions represents an important unmet medical need [3]. Cough hypersensitivity has recently emerged as a key pathophysiological feature and treatable trait in these patients [4–7].
- Open Access
- 23 April 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (5)
Prevalence and associated factors of cough syncope in patients with chronic cough: a multicentre prospective study
Cough syncope is a clinically significant complication of coughing, yet its epidemiology in patients with chronic cough remains poorly characterized. This study aimed to estimate the prevalence and identify associated factors for cough syncope among patients with chronic cough. Data were analysed from the Korean Chronic Cough Registry, a multicentre prospective observational study. Adults with newly referred chronic cough were followed for one year. Cough syncope was defined based on patient self-reports at enrolment and the one-year follow-up visit. We compared clinical characteristics between patients with and without cough syncope and performed multivariable logistic regression to identify independent associated factors. Among 682 eligible participants, cough syncope was identified in 13 (1.9%, 95% CI, 1.0–3.2%). Patients with cough syncope were predominantly male (69.2% versus 31.1%; p=0.014) and had a higher median body mass index (30.5 versus 23.8 kg·m −2 ; p=0.001) compared to those without. They also exhibited a higher rate of refractory chronic cough (RCC) (84.6% versus 46.2%; p=0.006) and reported greater cough severity and hypersensitivity at one year, despite more frequent use of neuromodulators and opiates. Multivariable analysis identified obesity (adjusted odds ratio [aOR] 4.65, 95% CI 1.24–17.47), RCC (aOR 4.08, 95% CI 1.09–15.23), and male sex (aOR 3.66, 95% CI 1.06–12.68) as independently associated with cough syncope. Cough syncope affects approximately 2% of patients with chronic cough and is associated with male sex, obesity, and refractory chronic cough, defining a distinct high-risk phenotype that warrants targeted risk stratification and prevention.
- 23 April 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (5)
Open AccessPrevalence and associated factors of cough syncope in patients with chronic cough: a multicentre prospective study
Cough syncope is a clinically significant complication of coughing, yet its epidemiology in patients with chronic cough remains poorly characterized. This study aimed to estimate the prevalence and identify associated factors for cough syncope among patients with chronic cough. Data were analysed from the Korean Chronic Cough Registry, a multicentre prospective observational study. Adults with newly referred chronic cough were followed for one year. Cough syncope was defined based on patient self-reports at enrolment and the one-year follow-up visit. We compared clinical characteristics between patients with and without cough syncope and performed multivariable logistic regression to identify independent associated factors. Among 682 eligible participants, cough syncope was identified in 13 (1.9%, 95% CI, 1.0–3.2%). Patients with cough syncope were predominantly male (69.2% versus 31.1%; p=0.014) and had a higher median body mass index (30.5 versus 23.8 kg·m −2 ; p=0.001) compared to those without. They also exhibited a higher rate of refractory chronic cough (RCC) (84.6% versus 46.2%; p=0.006) and reported greater cough severity and hypersensitivity at one year, despite more frequent use of neuromodulators and opiates. Multivariable analysis identified obesity (adjusted odds ratio [aOR] 4.65, 95% CI 1.24–17.47), RCC (aOR 4.08, 95% CI 1.09–15.23), and male sex (aOR 3.66, 95% CI 1.06–12.68) as independently associated with cough syncope. Cough syncope affects approximately 2% of patients with chronic cough and is associated with male sex, obesity, and refractory chronic cough, defining a distinct high-risk phenotype that warrants targeted risk stratification and prevention.
- Open Access
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (4) , 507-524
KAAACI Consensus Document on the Goals and Standards of Chronic Cough Clinics in Korea: A Delphi Study
Kim MY, et al. Allergy Asthma Immunol Res. 2026 Jul;18(4):507-524. https://doi.org/10.4168/aair.2026.18.4.507
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (4) , 507-524
Open AccessKAAACI Consensus Document on the Goals and Standards of Chronic Cough Clinics in Korea: A Delphi Study
Kim MY, et al. Allergy Asthma Immunol Res. 2026 Jul;18(4):507-524. https://doi.org/10.4168/aair.2026.18.4.507
- Open Access
- 1 January 2026
- Published by XMLink in Immune Network
- Vol. 26 (3) , e21
Synergistic Induction of Neutrophilic Inflammatory Programs by Staphylococcus aureus and Cigarette Smoke in Airway Epithelial Cells
Staphylococcus aureus (SA) colonization and cigarette smoking are both implicated in the pathogenesis of chronic airway disease, yet their combined effects on epithelial responses remain unclear. We investigated transcriptomic changes in human bronchial epithelial cells (BEAS-2B) following co-exposure to SA and cigarette smoke extract (CSE). RNA sequencing revealed that combined SA+CSE co-exposure was associated with a marked increase in differentially expressed genes, compared with single exposures. Functional enrichment and network analyses identified significant activation of pathways related to neutrophil migration, extracellular matrix remodeling, and inflammatory cascades, including TNF and IL-17 signaling. Key hub genes, notably CCL20, CXCL1, CXCL8, and IL-24, showed marked synergistic upregulation, which was validated by quantitative RT-PCR. These findings suggest that SA and cigarette smoke co-exposure is associated with a transcriptomic profile suggestive of neutrophilic inflammation. The involvement of IL-24 and IL-17 signaling suggests potential pathways linking bacterial colonization and smoking to airway inflammation and remodeling.
- 1 January 2026
- Published by XMLink in Immune Network
- Vol. 26 (3) , e21
Open AccessSynergistic Induction of Neutrophilic Inflammatory Programs by Staphylococcus aureus and Cigarette Smoke in Airway Epithelial Cells
Staphylococcus aureus (SA) colonization and cigarette smoking are both implicated in the pathogenesis of chronic airway disease, yet their combined effects on epithelial responses remain unclear. We investigated transcriptomic changes in human bronchial epithelial cells (BEAS-2B) following co-exposure to SA and cigarette smoke extract (CSE). RNA sequencing revealed that combined SA+CSE co-exposure was associated with a marked increase in differentially expressed genes, compared with single exposures. Functional enrichment and network analyses identified significant activation of pathways related to neutrophil migration, extracellular matrix remodeling, and inflammatory cascades, including TNF and IL-17 signaling. Key hub genes, notably CCL20, CXCL1, CXCL8, and IL-24, showed marked synergistic upregulation, which was validated by quantitative RT-PCR. These findings suggest that SA and cigarette smoke co-exposure is associated with a transcriptomic profile suggestive of neutrophilic inflammation. The involvement of IL-24 and IL-17 signaling suggests potential pathways linking bacterial colonization and smoking to airway inflammation and remodeling.
- Open Access
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (1) , 55-66
RFC1 Repeat Expansion in Chronic Cough: Findings From the Korean Chronic Cough Registry
Park KE, et al. Allergy Asthma Immunol Res. 2026 Jan;18(1):55-66. https://doi.org/10.4168/aair.2026.18.1.55
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (1) , 55-66
Open AccessRFC1 Repeat Expansion in Chronic Cough: Findings From the Korean Chronic Cough Registry
Park KE, et al. Allergy Asthma Immunol Res. 2026 Jan;18(1):55-66. https://doi.org/10.4168/aair.2026.18.1.55
- 18 April 2025
- Published by Springer Nature in Lung
- Vol. 203 (1) , 1-7
Exploration of IgE Specific to Staphylococcal Serine Protease-Like Protein A as a Phenotypic Marker in Late-Onset Asthma
Purpose Staphylococcus aureus (SA) secretes pro-allergic molecules, including staphylococcal enterotoxins (SEs) and serine protease-like proteins (Spls). While IgE sensitization to SE has been relatively well documented in relation to severe eosinophilic late-onset asthma, the clinical implications of IgE sensitization to Spls remain unclear. We explored the clinical relevance of Spl-IgE in late-onset asthmatics. Methods Adults with late-onset asthma (onset age ≥ 40 years) were prospectively enrolled. Demographic and clinical characteristics were assessed, and serum levels of total IgE, SE-IgE, and SplA-IgE were measured. Nasal swabs were obtained to assess SA colonization. Results Among 109 participants, SplA-IgE levels were significantly associated with blood eosinophilia, total IgE, SE-IgE sensitization, and male sex, but not with SA colonization, asthma severity, or lung function. Conclusion Sensitization to SplA-IgE may indicate a type 2 inflammatory phenotype, but its role in asthma warrants further investigation.
- 18 April 2025
- Published by Springer Nature in Lung
- Vol. 203 (1) , 1-7
Exploration of IgE Specific to Staphylococcal Serine Protease-Like Protein A as a Phenotypic Marker in Late-Onset Asthma
Purpose Staphylococcus aureus (SA) secretes pro-allergic molecules, including staphylococcal enterotoxins (SEs) and serine protease-like proteins (Spls). While IgE sensitization to SE has been relatively well documented in relation to severe eosinophilic late-onset asthma, the clinical implications of IgE sensitization to Spls remain unclear. We explored the clinical relevance of Spl-IgE in late-onset asthmatics. Methods Adults with late-onset asthma (onset age ≥ 40 years) were prospectively enrolled. Demographic and clinical characteristics were assessed, and serum levels of total IgE, SE-IgE, and SplA-IgE were measured. Nasal swabs were obtained to assess SA colonization. Results Among 109 participants, SplA-IgE levels were significantly associated with blood eosinophilia, total IgE, SE-IgE sensitization, and male sex, but not with SA colonization, asthma severity, or lung function. Conclusion Sensitization to SplA-IgE may indicate a type 2 inflammatory phenotype, but its role in asthma warrants further investigation.